PRTK - Paratek Pharmaceuticals Inc. (PRTK) CEO Evan Loh on Q4 2020 Results - Earnings Call Transcript
Paratek Pharmaceuticals, Inc. (PRTK) Q4 2020 Earnings Conference Call February 24, 2021 4:30 PM ET Company Participants Ben Strain - Vice President of Investor Relations Evan Loh - Chief Executive Officer Adam Woodrow - President and Chief Commercial Officer Randy Brenner - Chief Development and Regulatory Officer Conference Call Participants Eason Lee - SVB Leerink Thomas Yip - H.C. Wainwright Kevin Kedra - G. Research Bert Hazlett - BTIG Presentation Operator Greetings and welcome to the Paratek Pharmaceuticals Fourth Quarter and Full Year 2020 Earnings Conference Call. At this time all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a remainder this conference is being recorded. I'd now like to turn the conference over to your host Ben Strain, Vice President of Investor Relations. Please go ahead, sir. Ben Strain Good afternoon, and welcome to Paratek's fourth quarter and full year
For further details see:
Paratek Pharmaceuticals, Inc. (PRTK) CEO Evan Loh on Q4 2020 Results - Earnings Call Transcript